ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135077; 2) Community: the network communities that were significantly associated with the response to NSC 135077; 3) Molecule: the relationships between components within communities and NSC 135077; 4) MDR: the compounds that were significantly associated with the NSC 135077.

NSC Compound Enrichment Correlation
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.00211131723826696 0.28191204
NSC 664271 Null 0.00211131723826696 0.39690833
NSC 679822 Naphth[2,3-d]oxazol-9(4H)-one, 2-methyl- 4-[4-(4-morpholinyl)phenylimino]- 0.00211131723826696 0.32615398
NSC 687526 Null 0.00211131723826696 0.19077415
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.00216000169440201 0.34265075
NSC 363812 Tetraplatin 0.00216000169440201 0.39318461
NSC 623599 4-Methyl-1,2,4-benzotriazin-3(4H)-imine 1-oxide, hydrochloride 0.00216000169440201 0.2680255
NSC 624771 5H-Benzocyclohepten-5-one, 4-(acetyloxy)-6,6-dibromo- 6,7,8,9-tetrahydro- 0.00216000169440201 0.35871909
NSC 641054 Null 0.00216000169440201 0.32950102
NSC 656203 Discorhabdin B 0.00216000169440201 0.1894205
Total:126  Current:14    [First] [Prev] [Next] [Last]